current treatment landscape in classical mpns
Published 6 years ago • 78 plays • Length 1:54Download video MP4
Download video MP3
Similar videos
-
1:14
an overview of the current and future treatment landscape for mpns
-
2:03
the current landscape of treatment for bpdcn
-
2:18
the current landscape of treatment for bpdcn
-
0:45
current landscape of treatment for scd: an update from ash 2023
-
2:55
mpns: a changing treatment landscape
-
1:23
the current landscape of treatment for hr-mds: an update from ash 2023
-
0:56
the current treatment landscape in cll
-
5:19
the current treatment landscape for multiple myeloma and trials investigating novel combinations
-
0:56
the role of navtemadlin in the mpn treatment landscape
-
2:36
the current treatment landscape for aml
-
1:51
checkpoint inhibition in the treatment of mpns
-
1:29
the current landscape of maintenace therapy in aml and areas for future exploration
-
1:53
the current immunotherapeutic landscape for treatment of dlbcl
-
2:21
the potential applications for immunotherapy in mpns
-
1:47
the role of ngs in improving diagnosis in mpns
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
1:29
the current landscape of immunotherapy for aml: an update from ash 2023
-
2:16
phase i study of donor-derived γδ t cells as relapse prophylaxis post haplo/cy